Company: BKYI
Filing Date: 2025-04-25
Form Type: S-1
Source: 0001437749-25-013165
Chunk: 8

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-25
Form: S-1
Chunk 8
---
 located at 101 Crawfords Corner Road, Suite 4116, Holmdel, New Jersey 07733 and our telephone number is (732) 359-1100. Our website is located at www.bio-key.com. The information on our website or any other website is not incorporated by reference into this prospectus. Our website address is included as an inactive textual reference only.

The BIO-key logo is our trademark. This prospectus and the documents we incorporate by reference into this prospectus may also contain trademarks and trade names of others.

<div align='center'>3</div>

The Offering

| Issuer:                                                                                                                                                             | BIO-key International, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Common stock offered by selling stockholder:                                                                                                                        | 3,091,668 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Common stock outstanding before this offering:                                                                                                                      | 5,814,041 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Common stock outstanding after completion of this offering (assuming full exercise of the warrants that are exercisable for shares of common stock offered hereby): | 8,905,709 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Terms of this offering:                                                                                                                                             | The selling stockholder, including its transferees, donees, pledgees, assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the shares of common stock offered by this prospectus from time to time on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price, or at negotiated prices.                                     |
| Use of proceeds:                                                                                                                                                    | The proceeds from the sale of the securities covered by this prospectus will be received by the selling stockholder. We will not receive any of the proceeds from any sale of the shares of common stock offered by this prospectus. If all of the Series A Warrants and Series B Warrants exercisable for shares of common stock offered hereby are exercised, we will receive aggregate gross proceeds of $6,647,086.20 which we expect to use for working capital purposes and general corporate purposes, including repayment of a portion of the Company’s outstanding secured note. See “Use of Proceeds”. |
| Listing of common stock:                                                                                                                                            | Our common stock is listed on the Nasdaq Capital